Identifying disease modifying genes in multiple sclerosis

被引:100
|
作者
Kantarci, OH
de Andrade, M
Weinshenker, BG
机构
[1] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
multiple sclerosis; genetics; prognosis; severity; course; outcome;
D O I
10.1016/S0165-5728(01)00481-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evidence is mounting that genetic variation influences not only susceptibility to multiple sclerosis (MS), but also its course and severity. Identification of disease modifying genes, however, poses unique challenges, especially on how to classify the course and outcome of the disease in ways that may be relevant to analysis of biological factors that might be influenced by genes, The power of the statistical approaches to detect small effects of individual genes in complex disorders such as MS is problematic, and approaches to estimate power must be appropriate for the data. Nonetheless, using contemporary schemes of classification, genetic variants that influence disease course have been found; in fact, a small number have been confirmed to influence disease course in two or more independent studies. This review addresses strategies relevant to identification of disease modifying genes in MS, and summarizes and critically evaluates the cur-rent state of knowledge in this area. (C) 2002 Elsevier Science B.V All rights reserved.
引用
收藏
页码:144 / 159
页数:16
相关论文
共 50 条
  • [41] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Kretzschmar, Benedikt
    Pellkofer, Hannah
    Weber, Martin S.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (04)
  • [42] Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis
    Bross, Madeline
    Hackett, Melody
    Bernitsas, Evanthia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 15
  • [43] Disease-modifying therapies in Chinese children with multiple sclerosis
    Yang, Fen
    Huang, De-hui
    Yang, Yang
    Wu, Wei-ping
    TURKISH JOURNAL OF PEDIATRICS, 2014, 56 (05) : 482 - 486
  • [44] Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies
    Porwal, Mokshal H.
    Salter, Amber
    Patel, Dhruvkumar
    Obeidat, Ahmed Z.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2022, 14
  • [45] Effects of disease modifying treatments on cognitive dysfunction in multiple sclerosis
    Giancarlo Comi
    Neurological Sciences, 2010, 31 : 261 - 264
  • [46] Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis
    Sombekke, Madeleine H.
    Arteta, David
    van de Wiel, Mark A.
    Crusius, J. Bart A.
    Tejedor, Diego
    Killestein, Joep
    Martinez, Antonio
    Pena, A. Salvador
    Polman, Chris H.
    Uitdehaag, Bernard M. J.
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (06) : 652 - 659
  • [47] Adherence to disease-modifying therapies in patients with multiple sclerosis
    Koltuniuk, Aleksandra
    Rosinczuk, Joanna
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1557 - 1565
  • [48] Impact of Disease-Modifying Therapies on Fatigue in Multiple Sclerosis
    Voelter, H. U.
    Hildebrandt, H.
    Kastrup, A.
    AKTUELLE NEUROLOGIE, 2016, 43 (08) : 511 - 518
  • [49] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Benedikt Kretzschmar
    Hannah Pellkofer
    Martin S. Weber
    Current Neurology and Neuroscience Reports, 2016, 16
  • [50] Prescribing of disease modifying agents in older adults with multiple sclerosis
    Talwar, Ashna
    Earla, Jagadeswara R.
    Hutton, George J.
    Aparasu, Rajender R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57